| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/03/1997 | WO1997012051A1 Pharmaceutical composition useful for nucleic acid transfection, and use thereof |
| 04/03/1997 | WO1997012037A1 A novel haemopoietin receptor and genetic sequences encoding same |
| 04/03/1997 | WO1997011718A1 Inhibitors of integrin receptors and their therapeutical uses |
| 04/03/1997 | WO1997011716A1 Manipulation of non-terminally differentiated cells using the notch pathway |
| 04/03/1997 | WO1997011701A1 Compositions for treating inflammation containing certain prostaglandins and a selective cyclooxygenase-2 inhibitor |
| 04/03/1997 | WO1997011692A2 Protein tyrosine kinase inhibitors for treating osteoarthritis |
| 04/03/1997 | WO1997011686A1 Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions |
| 04/03/1997 | WO1997011684A1 Use of heparinases to decrease inflammatory responses |
| 04/03/1997 | CA2233343A1 Use of heparinases to decrease inflammatory responses |
| 04/03/1997 | CA2233138A1 Inhibitors of integrin receptors and their therapeutical uses |
| 04/03/1997 | CA2231550A1 Compositions for treating inflammation containing certain prostaglandins and a selective cyclooxygenase-2 inhibitor |
| 04/03/1997 | CA2231064A1 Pharmaceutical composition useful for nucleic acid transfection, and use thereof |
| 04/03/1997 | CA2230121A1 Product and process to regulate actin polymerization |
| 04/02/1997 | EP0765668A1 Extract of Iridaceas and composition containing it |
| 04/02/1997 | EP0765666A1 Inhibition of irregular binding of lens cells |
| 04/02/1997 | EP0765168A1 Compositions and methods for the treatment of tumors |
| 04/02/1997 | EP0765151A1 Antibacterial oil-in-water emulsions |
| 04/02/1997 | EP0683661B1 Cosmetic and dermatological photoprotective formulations containing inorganic micro-pigments |
| 04/02/1997 | EP0680323B1 Synergising association having an antagonist effect on nk1 and nk2 receptors |
| 04/02/1997 | EP0670735B1 Peripheralization of hematopoietic stem cells |
| 04/02/1997 | EP0573465B1 Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same |
| 04/02/1997 | CN1146720A New pharmaceutical formulation and preparation process |
| 04/01/1997 | US5616720 Treating 1,6-diphenyl- or dihetero-substituted 2,5-diaminohexanol/3-/ with tetraalkoxytitanium, then amidation of reaction product and acylation yield stable viricides |
| 04/01/1997 | US5616593 Compositions containing piperine |
| 04/01/1997 | US5616580 Pharmacological composition for preventing neurotoxic side effects of NMDA antagonists |
| 04/01/1997 | US5616578 Method of treating human immunodeficiency virus infection using a cyclic protease inhibitor in combination with a reverse transcriptase inhibitor |
| 03/27/1997 | WO1997011366A1 Histone deacetylase as target for antiprotozoal agents |
| 03/27/1997 | WO1997011096A1 Anti-inflammatory agent |
| 03/27/1997 | WO1997010834A1 Bioactive factors of aloe vera plants |
| 03/27/1997 | WO1997010827A1 Use of antimineralocorticoid compounds against drug withdrawal syndrome |
| 03/27/1997 | WO1997010824A1 Use of 5ht1b receptor antagonist for the treatment of vascular disease |
| 03/27/1997 | WO1997010823A1 5-ht3 receptor antagonists for dyskinesia |
| 03/27/1997 | WO1997010821A1 Enhancement of erectile function with renin-angiotensin system inhibitors |
| 03/27/1997 | WO1997010819A1 Treating niddm with rxr agonists |
| 03/27/1997 | WO1997010818A1 Method and composition for treating mammalian diseases caused by inflammatory response |
| 03/27/1997 | WO1997010813A1 Ppar gamma antagonists for treating obesity |
| 03/27/1997 | WO1997010806A1 Aerosol compositions |
| 03/27/1997 | WO1997005873A3 Use of fluconazole for inhibiting the growth of cancers |
| 03/27/1997 | WO1997005859A3 Use of alicyclic diamines as immunomodulators |
| 03/27/1997 | WO1997004780A3 Pain-alleviating drug composition and method for alleviating pain |
| 03/27/1997 | WO1997001344A3 Method of dynamic retardation of cell cycle kinetics to potentiate cell damage |
| 03/27/1997 | WO1997000088A3 Rotavirus enterotoxin nsp4 and methods of using same |
| 03/27/1997 | WO1996039156A3 Phosphate-binding polymers for oral administration |
| 03/27/1997 | WO1996039053A3 Mineral supplements for dietetic food |
| 03/27/1997 | WO1996029974A3 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 03/27/1997 | CA2232360A1 Enhancement of erectile function with renin-angiotensin system inhibitors |
| 03/27/1997 | CA2231887A1 5-ht3 receptor antagonists for dyskinesia |
| 03/27/1997 | CA2231251A1 Histone deacetylase as target for antiprotozoal agents |
| 03/26/1997 | EP0764169A2 Drug salts |
| 03/26/1997 | EP0764028A2 Method of treating retained pulmonary secretions |
| 03/26/1997 | EP0764027A1 Method for protection against genotoxic mutagenesis |
| 03/26/1997 | EP0764026A1 Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders |
| 03/26/1997 | EP0764022A1 Agonists and antagonists of the nicotinic acetylcholine receptors of insects to control endoparasites |
| 03/26/1997 | EP0764021A1 Uterine fibroid treatment |
| 03/26/1997 | EP0639077B1 Drug for increasing the level of testosterone in the body |
| 03/26/1997 | EP0539493B1 Targeted drug delivery via phosphonate derivatives |
| 03/26/1997 | CN1146155A Method for implanting encapsulated cells in a host |
| 03/26/1997 | CN1145783A Pharmaceutical composition |
| 03/25/1997 | US5614649 Treatment of muscular disorders, substituted guanidines |
| 03/25/1997 | US5614561 Pyruvic acid and derivatives, fatty acid, topical |
| 03/25/1997 | US5614551 Inhibitors of fatty acid synthesis as antimicrobial agents |
| 03/25/1997 | US5614506 After angioplasty |
| 03/25/1997 | US5614501 Plant extracts as animal growth regulators, they contain polyphenol and arabinogalactan and are digested by bifidobacteria |
| 03/25/1997 | US5614496 Use of fibroblast growth factors to stimulate bone growth |
| 03/25/1997 | US5614220 Core with coating of water soluble enteric coating for release |
| 03/25/1997 | US5614191 Antitumor |
| 03/20/1997 | WO1997010507A1 Molecules that home to a selected organ or tissue in vivo and methods of identifying same |
| 03/20/1997 | WO1997010265A1 Nitrosated hemoglobins and therapeutic uses therefor |
| 03/20/1997 | WO1997009998A2 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors |
| 03/20/1997 | WO1997009987A1 Novel compositions based on a synergistic combination of one or more vrd ligands and retinoids |
| 03/20/1997 | WO1997009975A1 Topical anti-skin-cancer preparations |
| 03/20/1997 | WO1997009973A2 Peripherally active anti-hyperalgesic opiates |
| 03/20/1997 | WO1997009964A1 Microemulsions for use as vehicles for administration of active compounds |
| 03/20/1997 | WO1997006807A3 Contraceptive combined preparation, kits containing the same and contraceptive method using this combined preparation |
| 03/20/1997 | WO1997000952A3 A human edg-2 receptor homolog |
| 03/20/1997 | CA2356097A1 Peripherally active anti-hyperalgesic opiates |
| 03/20/1997 | CA2232043A1 Nitrosated hemoglobins and therapeutic uses therefor |
| 03/20/1997 | CA2232000A1 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors |
| 03/19/1997 | EP0763543A2 A method for preparing an inflammatory cytokine (MIP-2) and diagnostic and therapeutic applications for the cytokine or its antibody |
| 03/19/1997 | EP0763121A1 Method of cancer treatment by p53 protein control |
| 03/19/1997 | EP0763104A1 Human dna topoisomerase i-alpha |
| 03/19/1997 | EP0763046A1 Dna encoding gls1 |
| 03/19/1997 | EP0763016A1 Compositions and methods for treating mast-cell mediated conditions |
| 03/19/1997 | EP0762884A1 Modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof |
| 03/19/1997 | EP0762881A1 Method and reagents for the treatment of rheumatoid arthritis |
| 03/19/1997 | EP0762880A1 Retroviral protease inhibitor combinations |
| 03/19/1997 | EP0626861B1 Treatment for asthma |
| 03/19/1997 | CN1145586A Taste masked composition containing a drug/polymer complex |
| 03/18/1997 | US5612376 Topically applying 3-phenyllactic acid to human skin |
| 03/18/1997 | US5612365 Angiotensin II receptor antagonists for the treatment and prophylaxis of coronary heart disease |
| 03/18/1997 | US5612027 Eye surgery and maintaining pupil size by administering an acidic viscoelastic polymer |
| 03/18/1997 | US5612026 Anion exchange resin, xanthan gum, water soluble salt |
| 03/18/1997 | US5612016 Conjugates of antibodies and bifunctional ligands |
| 03/18/1997 | US5611793 Disinfecting or sterilization tissues of mouths or wounds by applying photosensitizers |
| 03/18/1997 | CA2076980C Method and product for promoting hair growth and treating skin conditions |
| 03/13/1997 | WO1997009348A2 Orphan receptor |
| 03/13/1997 | WO1997009343A2 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers |
| 03/13/1997 | WO1997009068A2 Interactive molecular conjugates |
| 03/13/1997 | WO1997009060A1 Method of treating insulin resistance |
| 03/13/1997 | WO1997009056A1 Extract of iridaceae and compositions containing such extract |